Tag: Cancer: Skin
Pathologists Vary in Suggested Therapy for Melanocytic Lesions
Variation may lead to undertreatment or overtreatment of melanocytic lesions
MicroRNAs 203 and 205 Are Prognostic in Cutaneous SCC
miR-205 expression in tumors with pathologic features indicating poor prognosis, in invasion front
Imiquimod Has Sustained Benefit for Basal Cell Carcinoma
Lower treatment success for imiquimod 5 percent than surgery, but rates similar at three, five years
Alcohol Intake Linked to Increase in Risk of Melanoma
Correlation stronger for melanoma in relatively UV-spared sites versus UV-exposed sites
Incidence of Sebaceous Carcinoma Up From 2000 to 2012
Higher all-cause mortality among males, blacks, and for extraocular anatomic locations
Clinical Features Can Be Used to Tailor Melanoma Screening
A tailored surveillance program could lead to greater precision in melanoma prevention
Myocarditis ID’d With Ipilimumab + Nivolumab in Melanoma
Case report describes two patients who developed fatal T-cell-driven drug reaction
Use of Term ‘Rule Out’ May Delay Dermatopathology Diagnosis
Use on requisition form linked to longer time to diagnosis, increased use of pathology stains, sections
Whites Have Longest Survival in Cutaneous Melanoma
For stages I and III, black patients have significantly lower survival, increased hazard ratios
Mohs Effective for Melanoma in Situ of Trunk, Extremities
Surgical margin of 9 mm needed to excise 97 percent of melanoma in situ